BRIEF published on 03/18/2026 at 07:05, 1 month 7 days ago Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3 FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease
BRIEF published on 03/18/2026 at 07:05, 1 month 7 days ago Le venglustat de Sanofi obtient la désignation de thérapie innovante pour la maladie de Gaucher de type 3 FDA Sanofi Thérapie Révolutionnaire Venglustat Maladie De Gaucher
BRIEF published on 03/18/2026 at 07:05, 1 month 7 days ago Sanofi : Désignation de thérapie innovante pour le venglustat aux États-Unis FDA Sanofi Venglustat Maladie De Gaucher Découverte Médicale
BRIEF published on 03/18/2026 at 07:05, 1 month 7 days ago Sanofi: Breakthrough Therapy Designation for venglustat in the United States FDA Sanofi Venglustat Medical Discovery Gaucher's Disease
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago Heidelberg Pharma to Receive Milestone Payment for HDP-101 Study in China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment Huadong Medicine
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago Heidelberg Pharma recevra un paiement d'étape pour l'étude HDP-101 en Chine Heidelberg Pharma HDP-101 Étude Clinique Paiement D'étape Médecine Huadong
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago SMG Swiss Marketplace Group Reports Strong 2025 Financial Performance AI Innovation Revenue Growth Board Changes Dividends 2025 Financial Results
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago SMG Swiss Marketplace Group annonce de solides performances financières pour 2025 Croissance Des Revenus Dividendes Innovation En IA Changements Au Conseil D'administration Résultats Financiers De 2025
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago TAG Immobilien AG Surpasses 2025 Financial Targets FFO I And II Valuation Growth Real Estate Acquisitions Decarbonisation Progress Poland Sales Success
BRIEF published on 03/18/2026 at 07:00, 1 month 7 days ago TAG Immobilien AG dépasse ses objectifs financiers pour 2025 Acquisitions Immobilières FFO I Et II Croissance De La Valorisation Progrès En Matière De Décarbonation Succès Des Ventes En Pologne
Published on 04/25/2026 at 03:10, 21 hours 35 minutes ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 1 day 2 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:05, 1 day 2 hours ago Critical Elements Pleure la perte de son administrateur Marc Simpson
Published on 04/24/2026 at 22:00, 1 day 2 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 1 day 9 hours ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/25/2026 at 16:25, 8 hours 20 minutes ago Leading a New Era of Family Mobility! CHERY TIGGO V, the 3-in-1 Family Vehicle, Debuts at AutoChina2026
Published on 04/24/2026 at 22:43, 1 day 2 hours ago EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 1 day 2 hours ago Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:30, 1 day 6 hours ago EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 1 day 6 hours ago EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Published on 04/25/2026 at 07:00, 17 hours 45 minutes ago DLSI - Chiffre d'affaires 1er trimestre 2026
Published on 04/24/2026 at 18:48, 1 day 5 hours ago Laboratoires Euromedis - Communiqué résultat 2025
Published on 04/24/2026 at 18:00, 1 day 6 hours ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 1 day 7 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
